GLMD
Galmed Pharmaceuticals Ltd.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 6-K | 4/14/2026 | View on SEC |
| 6-K | 4/9/2026 | View on SEC |
| EFFECT | 4/1/2026 | View on SEC |
| POS AM | 3/31/2026 | View on SEC |
| 20-F | 3/31/2026 | View on SEC |
| 3 | 3/18/2026 | View on SEC |
| 3 | 3/18/2026 | View on SEC |
| 3 | 3/18/2026 | View on SEC |
| 3 | 3/18/2026 | View on SEC |
| 3 | 3/18/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GLMD |
| Company Name | Galmed Pharmaceuticals Ltd. |
| CIK | 1595353 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | L3 |
| Phone | 97236938448 |